Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma of the Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Not applicableNot Yet RecruitingNCT06062589
What this trial is testing

AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 18
Early research (Phase 1)Looking for participantsNCT07524322
What this trial is testing

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+6 more
Regor Pharmaceuticals Inc. 63
Not applicableEnrolling By InvitationNCT06810895
What this trial is testing

Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix

Who this might be right for
Cervix CancerCadonilimabSmall Cell Neuroendocrine Carcinoma of the Cervix
Ding Ma 20
Testing effectiveness (Phase 2)Looking for participantsNCT04865887
What this trial is testing

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

Who this might be right for
Cervical CancerMetastatic Cervical Cancer
Georgetown University 35
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Post-approval studies (Phase 4)Looking for participantsNCT06952660
What this trial is testing

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Pfizer 100
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Not applicableUnknownNCT05883670
What this trial is testing

Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer
Shandong University 118
Testing effectiveness (Phase 2)Ended earlyNCT03108495
What this trial is testing

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Iovance Biotherapeutics, Inc. 210
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Not applicableUnknownNCT03778268
What this trial is testing

Sentinel Lymph Node Mapping In Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Peking University People's Hospital 1,143
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023
What this trial is testing

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Who this might be right for
HPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more
Transgene 143
Next Page